2022
DOI: 10.1016/j.carres.2021.108478
|View full text |Cite
|
Sign up to set email alerts
|

Identification of raloxifene as a novel α-glucosidase inhibitor using a systematic drug repurposing approach in combination with cross molecular docking-based virtual screening and experimental verification

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 35 publications
0
1
0
Order By: Relevance
“…For this purpose, inhibition of glucose hydrolyzing enzymes like amylase and glucosidase is necessary. [21][22][23] The alpha-amylase (-1,4-glucan-4-glucanohydrolases) is the most prominent enzyme as secretory product of salivary gland and that of pancreas. It is responsible for the conversion of mixture of complex carbohydrates to oligosaccharides and disaccharides by hydrolysis.…”
Section: Introductionmentioning
confidence: 99%
“…For this purpose, inhibition of glucose hydrolyzing enzymes like amylase and glucosidase is necessary. [21][22][23] The alpha-amylase (-1,4-glucan-4-glucanohydrolases) is the most prominent enzyme as secretory product of salivary gland and that of pancreas. It is responsible for the conversion of mixture of complex carbohydrates to oligosaccharides and disaccharides by hydrolysis.…”
Section: Introductionmentioning
confidence: 99%